Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Guidelines of care for the management of psoriasis and psoriatic arthritis
Alan Menter, Neil J. Korman, Craig A. Elmets, et al.
Journal of the American Academy of Dermatology (2009) Vol. 61, Iss. 3, pp. 451-485
Closed Access | Times Cited: 532

Showing 1-25 of 532 citing articles:

Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
April W. Armstrong, Charlotte Read
JAMA (2020) Vol. 323, Iss. 19, pp. 1945-1945
Closed Access | Times Cited: 1581
Guidelines of care for the management of atopic dermatitis
Lawrence F. Eichenfield, Wynnis L. Tom, Sarah L. Chamlin, et al.
Journal of the American Academy of Dermatology (2013) Vol. 70, Iss. 2, pp. 338-351
Open Access | Times Cited: 1092
Guidelines of care for the management of atopic dermatitis
Robert Sidbury, Dawn Marie R. Davis, David E. Cohen, et al.
Journal of the American Academy of Dermatology (2014) Vol. 71, Iss. 2, pp. 327-349
Open Access | Times Cited: 802
Guidelines of care for the management of psoriasis and psoriatic arthritis
Alice B. Gottlieb, Neil J. Korman, Kenneth B. Gordon, et al.
Journal of the American Academy of Dermatology (2008) Vol. 58, Iss. 5, pp. 851-864
Open Access | Times Cited: 768
Psoriasis
Jacqueline Greb, Ari M. Goldminz, James T. Elder, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 741
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
Laure Gossec, Josef S Smolen, C. Gaujoux-Viala, et al.
Annals of the Rheumatic Diseases (2011) Vol. 71, Iss. 1, pp. 4-12
Open Access | Times Cited: 452
Guidelines of care for the management of psoriasis and psoriatic arthritis
Alan Menter, Neil J. Korman, Craig A. Elmets, et al.
Journal of the American Academy of Dermatology (2011) Vol. 65, Iss. 1, pp. 137-174
Closed Access | Times Cited: 444
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
Arthur Kavanaugh, Philip J. Mease, Juan J. Gómez‐Reino, et al.
Annals of the Rheumatic Diseases (2014) Vol. 73, Iss. 6, pp. 1020-1026
Open Access | Times Cited: 425
Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
Peter Schäfer
Biochemical Pharmacology (2012) Vol. 83, Iss. 12, pp. 1583-1590
Closed Access | Times Cited: 395
Diagnosis and management of psoriasis.
Whan B. Kim, Dana Jerome, Jensen Yeung
PubMed (2017) Vol. 63, Iss. 4, pp. 278-285
Closed Access | Times Cited: 387
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
Gabrielle Kingsley, Anna Kowalczyk, Helen Taylor, et al.
Lara D. Veeken (2012) Vol. 51, Iss. 8, pp. 1368-1377
Open Access | Times Cited: 316
Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity
Peter Schäfer, Anastasia Parton, Lori Capone, et al.
Cellular Signalling (2014) Vol. 26, Iss. 9, pp. 2016-2029
Open Access | Times Cited: 278
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations
Alexander Nast, Catherine Smith, Phyllis I. Spuls, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 11, pp. 2461-2498
Open Access | Times Cited: 268
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
Christopher J Edwards, Francisco J. Blanco, Jeffrey Crowley, et al.
Annals of the Rheumatic Diseases (2016) Vol. 75, Iss. 6, pp. 1065-1073
Open Access | Times Cited: 261
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies
Alan Menter, Joel M. Gelfand, Cody Connor, et al.
Journal of the American Academy of Dermatology (2020) Vol. 82, Iss. 6, pp. 1445-1486
Open Access | Times Cited: 258
Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
Philip J. Mease, April W. Armstrong
Drugs (2014) Vol. 74, Iss. 4, pp. 423-441
Open Access | Times Cited: 248
Psoriasis: Which therapy for which patient
Shivani B. Kaushik, Mark Lebwohl
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 1, pp. 43-53
Open Access | Times Cited: 247
A clinical review of phototherapy for psoriasis
Ping Zhang, Mei X. Wu
Lasers in Medical Science (2017) Vol. 33, Iss. 1, pp. 173-180
Open Access | Times Cited: 239
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP
Hideki Fujita, Tadashi Terui, Koremasa Hayama, et al.
The Journal of Dermatology (2018) Vol. 45, Iss. 11, pp. 1235-1270
Open Access | Times Cited: 213
A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial
Maurizio Cutolo, Gary E. Myerson, Roy Fleischmann, et al.
The Journal of Rheumatology (2016) Vol. 43, Iss. 9, pp. 1724-1734
Closed Access | Times Cited: 199
Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council
Bruce Strober, Caitriona Ryan, Peter van de Kerkhof, et al.
Journal of the American Academy of Dermatology (2019) Vol. 82, Iss. 1, pp. 117-122
Open Access | Times Cited: 184
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations
Alexander Nast, Catherine Smith, Phyllis I. Spuls, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 2, pp. 281-317
Open Access | Times Cited: 146
2021 European guideline for the management of vulval conditions
W I van der Meijden, M. J. Boffa, Bram ter Harmsel, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 7, pp. 952-972
Closed Access | Times Cited: 90
Methotrexate-loaded hyaluronan-modified liposomes integrated into dissolving microneedles for the treatment of psoriasis
Shulin Shen, Zheng Xi, Dong Xu, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 195, pp. 106711-106711
Open Access | Times Cited: 17
A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis
Kristian Reich, Richard Langley, Kim Papp, et al.
New England Journal of Medicine (2011) Vol. 365, Iss. 17, pp. 1586-1596
Open Access | Times Cited: 197
Page 1 - Next Page

Scroll to top